Matrix metalloproteinase 9 contributes to gut microbe homeostasis in a model of infectious colitis

David M Rodrigues1, Andrew J Sousa, Steve P Hawley

  • 1Department of Paediatrics, University of Toronto, 27 Kings College Circle, Toronto, Ontario, Canada. philip.sherman@sickkids.ca

BMC Microbiology
|June 15, 2012
PubMed
Abstract

Insights

Matrix Metalloproteinase 9 (MMP-9) influences gut microbiome balance during bacterial colitis. MMP-9 deficiency protects against disease and preserves microbial diversity in mice, highlighting its role in inflammatory bowel disease pathogenesis.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Inflammatory bowel diseases (IBD) are linked to elevated Matrix Metalloproteinase 9 (MMP-9) expression.
  • Intestinal mucosal homeostasis is significantly disrupted in chronic IBD patients.
  • The role of MMP-9 in Citrobacter rodentium-induced colitis and gut microbiome disruption requires elucidation.

Purpose of the Study:

  • To investigate the contribution of MMP-9 to the pathogenesis of bacterial-induced colitis.
  • To assess the impact of MMP-9 on gut microbiome homeostasis during infection.
  • To determine if MMP-9 influences host-microbe interactions in the colon.

Main Methods:

  • Mice (wild-type and MMP-9-/-) were infected with Citrobacter rodentium.
  • Disease severity was evaluated via histology and intestinal permeability assays.
  • Inflammatory markers, fecal microbiome composition, and MMP-9 localization were analyzed.

Main Results:

  • MMP-9 localized to the colonic epithelium during C. rodentium infection.
  • Colitis severity (hyperplasia, barrier dysfunction) was similar between genotypes.
  • MMP-9 deficiency led to altered microbiome composition, increased protective bacteria (segmented filamentous bacteria), elevated IL-17, reduced C. rodentium colonization, and preserved microbial diversity.

Conclusions:

  • MMP-9 expression in the colon impacts the fecal microbiome.
  • MMP-9 plays a role in the pathogenesis of bacterial-induced colitis in mice.
  • Targeting MMP-9 may offer therapeutic potential for IBD by modulating the gut microbiome.

Related Concept Videos

Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...